[PRNewswire] JOYSBIO offers SARS-COV-2 Antigen Rapid Test that detects Omicron
전체 맥락을 이해하기 위해서는 본문 보기를 권장합니다.
"As new SARS-COV-2 mutations BA.4 and BA.5 pop up around the world," said Zhang, "The need for tests that can be counted on to show an active infection of new BA.4 and BA.5 variants continues to grow. Our mission, at JOYSBIO, is to provide tests that are fast, reliable, and efficient so people can get on with their lives as quickly as possible."
본고는 자료 제공사에서 제공한 것으로, 연합뉴스는 내용에 대해 어떠한 편집도 하지 않았음을 밝혀 드립니다.
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
subvariants BA.4 and BA.5
(TIANJIN, China, June 27, 2022 PRNewswire=연합뉴스) As the SARS-COV-2 Omicron subvariants BA.4 and BA.5 make their way across the EU and the US, Joysbio is able to give people the power to administer a rapid test for themselves at home. The Joysbio Coronavirus Antigen Rapid Test Kit can effectively detect the Omicron subvariants BA.4 and BA.5. The test is certified by CE1434 (PCBC) for self-testing by layperson.
Back in June 2020, Joysbio released their breakthrough testing COVID-19 antigen rapid test. The 15-minute results allow government officials, event organizers, school officials, and others to make decisions about distancing, mask wearing, and other precautions. More information about the test kit is available at https://en.joysbio.com/covid-19-antigen-rapid-test-kit/.
Since they released their first COVID antigen test, JOYSBIO has supplied more than 200 million of tests around the world to protect everyone from this deadly virus.
"As new SARS-COV-2 mutations BA.4 and BA.5 pop up around the world," said Zhang, "The need for tests that can be counted on to show an active infection of new BA.4 and BA.5 variants continues to grow. Our mission, at JOYSBIO, is to provide tests that are fast, reliable, and efficient so people can get on with their lives as quickly as possible."
Certified by CE1434 (PCBC) for self-testing by layperson, this is the one test that every home should have. At the first sign of symptoms or possible exposure, the test will be able to tell anyone whether it's COVID they're dealing with or some other illness.
The professional version of this test is recently included in the "EU Common List of COVID-19 rapid antigen tests" under Category A that is strongly recommended to use by the European Commission for the issuance of EU digital COVID certificates.
JOYSBIO (Tianjin) Biotechnology Co., Ltd. is an R&D-focused Chinese biotechnology company that develops, manufactures, and supplies high-quality medical in-vitro diagnostic (IVD) rapid test kits as well as revolutionary customized reagent kits to all parts of the world. JOYSBIO was founded by a team of professionals with many years of joint technical, marketing/sales, operational and manufacturing ability in this industry.
If you would like more information about this topic, please contact Rick Zhang at +86-186-0545-0986 or email at bd@joysbio.com.
Source: JOYSBIO (Tianjin) Biotechnology Co., Ltd.
[편집자 주] 본고는 자료 제공사에서 제공한 것으로, 연합뉴스는 내용에 대해 어떠한 편집도 하지 않았음을 밝혀 드립니다.
(끝)
출처 : PRNewswire 보도자료
Copyright © 연합뉴스 보도자료. 무단전재 및 재배포 금지.
- 의대 6년→5년 논란…"의사공백 최소화" vs "의료교육 부실화"(종합2보) | 연합뉴스
- 尹, 필리핀 도착…현지 싱크탱크 "깊은 유대와 가치 공유"(종합2보) | 연합뉴스
- 野, 부산 금정구청장 후보 민주당 김경지로 단일화(종합) | 연합뉴스
- 與, 재보선 긴장 역력…'당정 지지율 저조·野 단일화'에 촉각(종합) | 연합뉴스
- 석유냐 핵시설이냐…"이스라엘, 이란 직접타격 준비된 듯" | 연합뉴스
- "물가안정·내수부진에 금리인하 가능성"…38개월만의 피벗 임박 | 연합뉴스
- 응급실서 비응급 환자에 징수한 '페널티' 3천119억…역대 최대 | 연합뉴스
- 민주, 김여사특검법 재추진…거부권 없는 상설특검·국조도 병행 | 연합뉴스
- 與 "끝장볼 건 李방탄국감…文정부 의혹, 국감서 집요하게 지적" | 연합뉴스
- 국민연금 자동조정장치 도입시 20∼50대 수령액 7천만원 넘게 ↓ | 연합뉴스